PROTECTING YOUR RIGHT TO MEDICINES AND MEDICAL DEVICES
Sunday, 05 July 2020

Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. The concept of pharmacovigilance is borne out of the recognition that no medicine is completely risk-free.

The specific aims of pharmacovigilance are to:

  • improve patient care and safety in relation to the use of medicines and all medical and paramedical interventions,
  • improve public health and safety in relation to the use of medicines,
  • contribute to the assessment of benefit, harm, effectiveness and risk of medicines, encouraging their safe, rational and more effective (including cost-effective) use, and
  • promote understanding, education and clinical training in pharmacovigilance and its effective communication to the public.

Source: The Importance of Pharmacovigilance, WHO 2002

MCAZ houses the National Pharmacovigilance Centre which participates in the WHO Programme for International Drug Monitoring

The Authority wishes to notify stakeholders of the addition of several new methods of submitting Adverse Drug Reaction (ADR) reports, Serious Adverse Events (SAE) reports for clinical trials, Adverse Events Following Immunisation (AEFI) reports and SAE reports from pharmaceutical industry I E2B format.

The new methods include use of the Android Mobile App, Apple iOs Mobile App, Windows Desktop App, MacOs Desktop App, Linux Desktop App, as well as the Browser-Based Web App. These can be accessed from the respective links on this page.

 

Latest News

Draft Medicines and Allied Substances Control (Blood and Blood Components) Regulations

26 June 2020
Draft Medicines and Allied Substances Control (Blood and Blood Components) Regulations

 The draft Blood and Blood Components Regulations are now available Please note that this is a DRAFT  that has been uploaded to obtain comments from stakeholders before the regulations are...

Medical Product Alert ; Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

06 April 2020
Medical Product Alert ; Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

  This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat orcure COVID-19.   Medical...

Draft SADC Variations Guidelines

20 March 2020

Draft SADC Variations Guidelines are now available  Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet

Code of Ethics

22 August 2019
Code of Ethics

  In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...

SADC Guideline on Product Information and Labeling

10 July 2019
SADC Guideline on Product Information and Labeling

  Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...